July 22, 2019
Speculation is rife even earlier to Q2 reporting
Although, Friday’s tin could be today’s gold after a 38 of 45 “covered” companies declined!
Financing: Neuralstem (CUR) files for 1.3 M unit offering with no terms or pricing; HC Wainwright & Co is the banker … What a JOKE!
It's a daunting task to understand risk, seeing the unforeseen; on the basis of my own “rules”, I set-up my own “warning analysis” which isn’t machine oriented!
July 13, 2019
Volatility, algorithms, sustainability …
Add to the list, trend analysis, momentum’s magnitude, technicals and fundamentals – do they indicate expected pricing performance in 2019?
Why spend time finding sector news and analytics … it’s all right here!
News has become "something" sold into
July 19, 2019
Volume was low, the IBB closed DOWN -1.47% while the XBI closed DOWN -1.36% with the NASDAQ -0.74% as the Advance/Decline (A/D) line deteriorated to 4/38, 1 flat and 2 acquired
It’s not hard to be right so often, it’s about refining expectation, defining insight and trusting your “gut” versus the machines or algorithms
July 13, 2019
Volatility, algorithms, sustainability … Add to the list, trend analysis, momentum’s magnitude, technicals and fundamentals – do they indicate expected pricing performance in 2019? Why spend time finding sector news and analytics … it’s all right here! News has become "something" sold into
May 19, 2019
A scorecard of earnings of 45 covered companies 41 so far: 2 acquired (AST, OSIR) 1 on acquisition hold - ONCE) and 1 set to be reversed (HSGX) ... The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"
March 31, 2019
A scorecard of (AKA) earnings of 45 covered companies 44 out of 45 ... The current LPS (loss per share) or net income, cash positions i.e. "runways" - it's a reflection of this universe's investing "status"
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.
© 2019 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
